NanoSphere Health Sciences Inc. (NSHS.CN)
CAD 0.09
(70.0%)
CAD 0.09
(70.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 218.03 Thousand | 37.88 Thousand |
| Cost of Revenue | - | - | - | - | - | 19.45 Thousand |
| Gross Profit | - | - | - | - | 218.03 Thousand | 18.42 Thousand |
| Operating Expenses | 220.07 Thousand | 283.87 Thousand | 386 Thousand | 565.62 Thousand | 3.46 Million | 4.63 Million |
| Selling, General and Administrative Expenses | 196.99 Thousand | 256.96 Thousand | 326.47 Thousand | 551.86 Thousand | 2.25 Million | 3.91 Million |
| Research and Development Expenses | 23.08 Thousand | 26.9 Thousand | 59.53 Thousand | - | 4844.00 | 123.96 Thousand |
| Other Expenses | - | - | 27.63 Thousand | 13.76 Thousand | 1.2 Million | 597.57 Thousand |
| Cost and Expenses | 220.07 Thousand | 283.87 Thousand | 386 Thousand | 565.62 Thousand | 3.46 Million | 4.63 Million |
| Operating Income | -220.07 Thousand | -286 Thousand | -388.08 Thousand | -539.87 Thousand | -3.23 Million | -4.6 Million |
| Interest Expense | - | - | - | 8514.00 | 13.75 Thousand | 87.37 Thousand |
| Income Tax Expense | - | -4248.00 | -2101.00 | 25.59 Thousand | 20.88 Thousand | 172.8 Thousand |
| Earnings before Tax | -228.12 Thousand | -281.75 Thousand | -356.27 Thousand | -591.22 Thousand | -3.46 Million | -4.51 Million |
| Net Income | -228.13 | -277.5 Thousand | -354.16 Thousand | -616.81 Thousand | -3.48 Million | -4.51 Million |
| Earnings Per Share Basic | - | -0.03 | -0.05 | -0.11 | -0.65 | -0.93 |
| Earnings Per Share Diluted | - | -0.03 | -0.05 | -0.11 | -0.65 | -0.93 |
| Weighted Average Shares Outstanding | 10.27 Million | 10.27 Million | 6.81 Million | 5.41 Million | 5.36 Million | 4.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.27 Million | 10.27 Million | 6.81 Million | 5.41 Million | 5.36 Million | 4.83 Million |
| Gross Margin | - | - | - | - | 1.00 | 0.49 |
| EBIT Margin | - | - | - | - | -14.23 | -117.95 |
| Profit Margin | - | - | - | - | -16.00 | -119.18 |
| EBITDA | - | - | -341.26 Thousand | -529.77 Thousand | -3.1 Million | -4.46 Million |
| Earnings Before Tax Margin | - | - | - | - | -14.84 | -121.44 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 56.71 Thousand | 32.01 Thousand | 228.13 | 54.94 | 52.67 Thousand | 67.02 Thousand |
| Selling, General and Administrative Expenses | 44.51 Thousand | 26.46 Thousand | - | 44.38 | 45.11 Thousand | 60.02 Thousand |
| Research and Development Expenses | 7554.00 | 1503.00 | - | 12.65 | 4286.00 | 2490.00 |
| Other Expenses | 4649.00 | - | - | - | - | - |
| Cost and Expenses | 56.71 Thousand | 32.01 Thousand | 228.13 | 54.94 | 52.67 Thousand | 67.02 Thousand |
| Operating Income | -56.71 Thousand | -22.73 Thousand | -220.08 | -57.03 | -63.86 Thousand | -55.89 Thousand |
| Interest Expense | 350.00 | - | - | - | - | - |
| Income Tax Expense | -51.71 Thousand | -33.99 Thousand | -8.05 | 2.08 | -11.24 Thousand | 11.06 Thousand |
| Earnings before Tax | -61.05 Thousand | -41.29 Thousand | -228.13 | -54.94 | -41.47 Thousand | -78.15 Thousand |
| Net Income | -61.05 Thousand | -41.29 Thousand | -228.13 | -54.94 | -41.47 Thousand | -78.15 Thousand |
| Earnings Per Share Basic | -0.01 | -0.00 | - | - | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.00 | - | - | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million | 10.27 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -56.71 Thousand | -22.73 Thousand | - | 2.08 | -63.86 Thousand | -55.89 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ERMA
300748
2764
ADV
TIGER
CHMBBRW